- Home
- SGBX vs SCNI Comparison
SGBX vs SCNI Comparison
Compare SGBX & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- SCNI
- Stock Information
- Founded
- SGBX 2007
- SCNI 2003
- Country
- SGBX United States
- SCNI Israel
- Employees
- SGBX N/A
- SCNI N/A
- Industry
- SGBX RETAIL: Building Materials
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGBX Consumer Discretionary
- SCNI Health Care
- Exchange
- SGBX Nasdaq
- SCNI Nasdaq
- Market Cap
- SGBX 2.7M
- SCNI 3.2M
- IPO Year
- SGBX 2017
- SCNI N/A
- Fundamental
- Price
- SGBX $0.66
- SCNI $2.27
- Analyst Decision
- SGBX
- SCNI
- Analyst Count
- SGBX 0
- SCNI 0
- Target Price
- SGBX N/A
- SCNI N/A
- AVG Volume (30 Days)
- SGBX 1.1M
- SCNI 1.1M
- Earning Date
- SGBX 06-13-2025
- SCNI 08-14-2025
- Dividend Yield
- SGBX N/A
- SCNI N/A
- EPS Growth
- SGBX N/A
- SCNI N/A
- EPS
- SGBX N/A
- SCNI N/A
- Revenue
- SGBX $4,574,857.00
- SCNI $658,000.00
- Revenue This Year
- SGBX $1,628.82
- SCNI N/A
- Revenue Next Year
- SGBX N/A
- SCNI N/A
- P/E Ratio
- SGBX N/A
- SCNI N/A
- Revenue Growth
- SGBX N/A
- SCNI N/A
- 52 Week Low
- SGBX $0.30
- SCNI $1.90
- 52 Week High
- SGBX $2.95
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- SGBX 46.23
- SCNI 44.70
- Support Level
- SGBX $0.60
- SCNI $2.14
- Resistance Level
- SGBX $0.97
- SCNI $2.85
- Average True Range (ATR)
- SGBX 0.11
- SCNI 0.20
- MACD
- SGBX -0.03
- SCNI 0.01
- Stochastic Oscillator
- SGBX 22.73
- SCNI 20.55
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.